Tumor cell metabolism: Cancer's Achilles' heel

被引:1810
作者
Kroemer, Guido [1 ,2 ,3 ]
Pouyssegur, Jacques [4 ]
机构
[1] INSERM, U848, F-94805 Villejuif, France
[2] Inst Gustave Roussy, F-98405 Villejuif, France
[3] Univ Paris 11, F-98405 Villejuif, France
[4] Univ Nice, CNRS, Inst Signaling Dev Biol & Canc Res, Ctr Antoine Lacassagne,UMR 6543, F-06189 Nice, France
关键词
D O I
10.1016/j.ccr.2008.05.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The essential hallmarks of cancer are intertwined with an altered cancer cell-intrinsic metabolism, either as a consequence or as a cause. As an example, the resistance of cancer mitochondria against apoptosis-associated permeabilization and the altered contribution of these organelles to metabolism are closely related. Similarly, the constitutive activation of signaling cascades that stimulate cell growth has a profound impact on anabolic metabolism. Here, we review the peculiarities of tumor cell metabolism that might be taken advantage of for cancer treatment. Specifically, we discuss the alterations in signal transduction pathways and/or enzymatic machineries that account for metabolic reprogramming of transformed cells.
引用
收藏
页码:472 / 482
页数:11
相关论文
共 80 条
[31]   Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity [J].
Graff, Jeremy R. ;
Konicek, Bruce W. ;
Vincent, Thomas M. ;
Lynch, Rebecca L. ;
Monteith, David ;
Weir, Spring N. ;
Schwier, Phil ;
Capen, Andrew ;
Goode, Robin L. ;
Dowless, Michele S. ;
Chen, Yuefeng ;
Zhang, Hong ;
Sissons, Sean ;
Cox, Karen ;
McNulty, Ann M. ;
Parsons, Stephen H. ;
Wang, Tao ;
Sams, Lillian ;
Geeganage, Sandaruwan ;
Douglass, Larry E. ;
Neubauer, Blake Lee ;
Dean, Nicholas M. ;
Blanchard, Kerry ;
Shou, Jianyong ;
Stancato, Louis F. ;
Carter, Julia H. ;
Marcusson, Eric G. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09) :2638-2648
[32]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[33]   Hypoxia - A key regulatory factor in tumour growth [J].
Harris, AL .
NATURE REVIEWS CANCER, 2002, 2 (01) :38-47
[34]   ATP citrate lyase inhibition can suppress tumor cell growth [J].
Hatzivassiliou, G ;
Zhao, FP ;
Bauer, DE ;
Andreadis, C ;
Shaw, AN ;
Dhanak, D ;
Hingorani, SR ;
Tuveson, DA ;
Thompson, CB .
CANCER CELL, 2005, 8 (04) :311-321
[35]   Death and anti-death: Tumour resistance to apoptosis [J].
Igney, FH ;
Krammer, PH .
NATURE REVIEWS CANCER, 2002, 2 (04) :277-288
[36]   ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis [J].
Ishikawa, Kaori ;
Takenaga, Keizo ;
Akimoto, Miho ;
Koshikawa, Nobuko ;
Yamaguchi, Aya ;
Imanishi, Hirotake ;
Nakada, Kazuto ;
Honma, Yoshio ;
Hayashi, Jun-Ichi .
SCIENCE, 2008, 320 (5876) :661-664
[37]   Hypoxia-inducible factor I and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 [J].
Kim, Jung-Whan ;
Gao, Ping ;
Liu, Yen-Chun ;
Semenza, Gregg L. ;
Dang, Chi V. .
MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (21) :7381-7393
[38]   HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia [J].
Kim, JW ;
Tchernyshyov, I ;
Semenza, GL ;
Dang, CV .
CELL METABOLISM, 2006, 3 (03) :177-185
[39]   Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma [J].
Kim, Won ;
Yoon, Jung-Hwan ;
Jeong, Jae-Min ;
Cheon, Gi-Jeong ;
Lee, Tae-Sup ;
Yang, Jong-In ;
Park, Su-Cheol ;
Lee, Hyo-Suk .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (09) :2554-2562
[40]   Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP [J].
Ko, YH ;
Smith, BL ;
Wang, YC ;
Pomper, MG ;
Rini, DA ;
Torbenson, MS ;
Hullihen, J ;
Pedersen, PL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (01) :269-275